Ventana Roche Reports Flat Diagnostics Revenues in H1 At constant exchange rates, diagnostics revenues were up 2 percent, primarily due to the immunodiagnostics business. FDA Approves Roche's PD-L1 Test for Bladder Cancer The Ventana PD-L1 assay was approved as a complementary diagnostic for bladder cancer patients being considered for treatment with the immunotherapy Imfinzi. Loxo Oncology, Ventana Medical Systems Partner to Develop CDx The companies are aiming to develop and commercialize a test to identify patients likely to respond to Loxo's cancer drug larotrectinib. Roche's Ventana Lays Off 84 in Bid to Address Business Challenges In October, Roche reported the tissue diagnostics business contributed 8 percent to diagnostics sales in the first nine months of 2016. Transgenomic to Share Melbourne Research Data With Ventana Medical Systems The agreement gives Ventana access to results from a collaboration and licensing agreement that Transgenomic made separately with the University of Melbourne. Sep 1, 2016 Horizon, Ventana Partner on IHC Reference Standards for Cancer Tissue Diagnostics May 18, 2016 Roche Complementary Dx, Bladder Cancer Immunotherapy Get FDA Nod Jun 15, 2015 Ventana ALK IHC Test Gets FDA Approval as CDx for Pfizer's Xalkori May 27, 2015 Halozyme, Ventana Team Up for CDx Development Apr 14, 2015 Ventana Inks Master CDx Deal with Astellas Focusing Initially on FGFR Inhibitor Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.